Wakasaki T, Manako T, Yasumatsu R, Hara H, et al. Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study. PLoS One 2022;17:e0271907.
PMID: 35901098